XENE — Xenon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Xenon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	552	592	638	627	549
Net Total Accounts Receivable
Net Total Receivables	2.77	0.986	0.874	1.47	1.37
Prepaid Expenses
Total Current Assets	559	600	645	635	561
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.5	16.9	18.8	18.2	15.3
Long Term Investments
Other Long Term Assets
Total Assets	572	754	965	798	633
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.3	22.7	27.3	35.6	41.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22	32.6	36.9	43.2	51.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	550	721	928	755	582
Total Liabilities & Shareholders' Equity	572	754	965	798	633
Total Common Shares Outstanding
Total Preferred Shares Outstanding